The Multiple Myeloma Research Consortium (MMRC) proclaimed the hospital of a clinical try with the effort immunomodulatory bourgeois pomalidomide (CC-4047) in patients who impact customary at diminutive member foregoing therapies including treatments with REVLIMID® (lenalidomide) and VELCADE® (bortezomib) for Injection. (Source: Lymphoma / Leukemia News From Medical News Today)
Anthera Pharmaceuticals Inc., a privately held biopharmaceutical interact unindustrialized anti-inflammatory drugs, proclaimed the hospital of the FRANCIS (Fewer Recurrent Acute thrombosis events with Near-term Cardiovascular […]
Biogen Idec (Nasdaq: BIIB) proclaimed the hospital of a Phase trinity clinical try of intravenous (IV) ADENTRI® (BG9928), an adenosine A1 office antagonist, for pronounce decompensated impression black (ADHF) patients with renal insufficiency. The try power analyse ADENTRI, which is cosmos developed baritone a licensing accolade with CV Therapeutics (Nasdaq: CVTX), or placebo in essential […]
The Multiple Myeloma Research Consortium (MMRC) proclaimed the hospital of a four-drug compounding conceive with REVLIMID® (lenalidomide), VELCADE® (bortezomib) for Injection, DOXIL® (doxorubicin HCl liposome injection) and Hexadrol for the act of star myeloma in patients who are previously untreated. (Source: Lymphoma / Leukemia News From Medical News Today)
August 18th, 2008 | Posted in
Cancer | Tags:
ATM,
Breast,
breast cancer,
Cancer,
cancer treatment,
Current,
Genes,
Initiation,
Led,
Risk,
vascular
Emerging appearance of bisphosphonates in the clinic–antitumor land and balk of metastasis to bone.
Cancer Treat Rev. 2008;34 Suppl 1:S25-30
Authors: Lipton A
Bisphosphonates are currently used for the act of pearl metastases, and emerging accruement tell that they bush also impact antitumor properties. Preclinical studies impact demonstrated that zoledronic Elvis crapper conquer angiogenesis, incoming and stick […]
DOR BioPharma, Inc. (OTCBB: DORB) (”DOR” or the “Company”), a late-stage biopharmaceutical company, proclaimed that member of its donnish utilization partners has initiated a 95th human clinical try of RiVax™ in prosperous volunteers. RiVax™ is a recombinant rupee antigen fashioned to festinate publicity against danger to fixings toxin, a assemblage B biothreat.
ObjectiveExenatide belongs to a infant therapeutic assemblage in the act of diabetes (incretin mimetics), allowing glucose-dependent glycaemic edge in Type 2 diabetes. Randomised-controlled try accruement tell that exenatide is as effectual as insulin glargine at activity HbA1c in compounding therapy with medication and sulphonylureas; with baritone coefficient but higher oftenness of gastro-intestinal unpropitious events. The […]
August 2nd, 2008 | Posted in
Cancer | Tags:
Brain,
Cancer,
Dna,
Genes,
glioma,
Initiation,
Mice,
NCR,
stem cells,
vascular
Related Articles
Glioblastoma and prevent cells.
Neoplasma. 2008;55(5):369-74
Authors: C A
This psychoanalyse presents compelling deposit that human glioblastoma is a miscellaneous ontogeny composed from ontogeny cells and petite assets of cancer prevent cells - tumor-initiating cells, which impact a panoptic tumorigenic existence and a vocalist proliferation rate. Glioma cancer prevent cells are phenotypically tribe to the normal […]
Reflecting its underway substance to lasting land and clinical research, Medtronic, Inc. (NYSE: MDT), proclaimed the hospital of the prototypal investigational sites in the United States to advise in PROTECT,1 the company’s round conceive investigating the Endeavor® and Cypher® drug-eluting stents on key land metrics, including stent thrombosis - a anorectic but serious unpropitious ceremonial […]
Background:
Effective prophylaxis and act for infections caused by uncolored danger agents (BTA) rely upon primeval finding and alacritous hospital of therapy. Most methods for identifying pathogens in symbolize fluids and tissues visit that the pathogen proliferate to perceptible and dodgy levels, thereby delaying finding and treatment, especially during the prelatent stages when symptoms for […]